Kolexia
Foussard Ninon
Endocrinologie
CHU Bordeaux
Bordeaux, France
159 Activités
275 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 2 Diabète Diabète de type 1 Rétinopathie diabétique Ulcère du pied Pied diabétique Ulcère Diabète gestationnel Grossesse chez les diabétiques

Industries

Sanofi
6 collaboration(s)
Dernière en 2023
AstraZeneca
2 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
Diabetes & metabolism   11 février 2024
Predictors of major adverse lower limb events in patients with tissue loss secondary to critical limb-threatening ischemia.
Cardiovascular revascularization medicine : including molecular interventions   01 février 2024
The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures.
Cardiovascular diabetology   13 janvier 2024
SCADIAB: Does Screening of Coronary Artery Disease an Efficient Public Health Strategy in Patients With Type 2 DIABetes at Very High Cardiovascular Risk: Target Trial Emulation From the National Healthcare System Claims Databases in France
Essai Clinique (CHU Bordeaux)   29 décembre 2023
GLYCAGEST: New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.
Essai Clinique (CHU Bordeaux)   21 décembre 2023
🩺 Interview : découvrez nos spécialistes du diabète, Ninon FOUSSARD et Vincent RIGALLEAU !
Youtube @ LearnyLib   21 décembre 2023
Comment on Peker, T.; Boyraz, B. The Relationship between Resistant Hypertension and Advanced Glycation End-Product Levels Measured Using the Skin Autofluorescence Method: A Case-Control Study. 2023, , 6606.
Journal of clinical medicine   08 décembre 2023
Thrombosis in the Coronary Microvasculature Impairs Cardiac Relaxation and Induces Diastolic Dysfunction.
Arteriosclerosis, thrombosis, and vascular biology   30 novembre 2023
Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records.
Cardiovascular diabetology   28 novembre 2023
Thrombosis in the coronary microvasculature may be responsible for impaired cardiac relaxation and diastolic dysfunction
ESC Congress 2023 25–28 August 2023 Amsterdam, Netherlands Abstract Supplement   09 novembre 2023